WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000028968) DRUG DELIVERY DEVICE, ESPECIALLY FOR THE DELIVERY OF PROGESTINS AND ESTROGENS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/028968    International Application No.:    PCT/FI1999/000887
Publication Date: 25.05.2000 International Filing Date: 26.10.1999
Chapter 2 Demand Filed:    10.04.2000    
IPC:
A61K 9/00 (2006.01), A61K 31/565 (2006.01), A61K 31/57 (2006.01)
Applicants: LEIRAS OY [FI/FI]; P.O. Box 415 FIN-20101 Turku (FI) (For All Designated States Except US).
MARKKULA, Tommi [FI/GB]; (GB) (For US Only).
ALA-SORVARI, Juha [FI/FI]; (FI) (For US Only).
JUKARAINEN, Harri [FI/FI]; (FI) (For US Only).
LEHTINEN, Matti [FI/FI]; (FI) (For US Only).
RUOHONEN, Jarkko [FI/FI]; (FI) (For US Only)
Inventors: MARKKULA, Tommi; (GB).
ALA-SORVARI, Juha; (FI).
JUKARAINEN, Harri; (FI).
LEHTINEN, Matti; (FI).
RUOHONEN, Jarkko; (FI)
Agent: TURUN PATENTTITOIMISTO OY; P.O. Box 99 FIN-20521 Turku (FI)
Priority Data:
09/190,606 12.11.1998 US
Title (EN) DRUG DELIVERY DEVICE, ESPECIALLY FOR THE DELIVERY OF PROGESTINS AND ESTROGENS
(FR) DISPOSITIF D'ADMINISTRATION DE MEDICAMENTS, EN PARTICULIER DES PROGESTATIFS ET DES OESTROGENES
Abstract: front page image
(EN)The invention relates to a delivery device for the controlled release of a therapeutically active agent, especially a progestin or an estrogen, over a prolonged period of time, said device comprising a core comprising said therapeutically active agent, and a membrane encasing said core wherein said membrane is made of an elastomer. According to the invention, the elastomer is a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Si-atoms of the siloxane units.
(FR)L'invention concerne un dispositif d'administration permettant la libération contrôlée d'un agent thérapeutiquement actif, en particulier un progestatif ou un oestrogène, pendant une durée prolongée. Ledit dispositif comprend un noyau renfermant ledit agent thérapeutiquement actif, et une membrane enveloppant ledit noyau. Ladite membrane est faite d'un élastomère. L'élastomère est à base de siloxane comprenant des groupes 3,3,3-trifluoropropyle fixés aux atomes de Si des unités de siloxane.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)